Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
F DuboisA Goudeau

Abstract

The aims of this study were the following: 1) to estimate the prevalence of hepatitis C virus (HCV) antibody (anti-HCV) in a population-based survey of French residents not selected for risk factors; 2) to investigate the association between anti-HCV seropositivity, viremia, the infecting HCV genotype, and the alanine transaminase (ALT) level; and 3) to identify risk factors for HCV infection by a nested case control study within this survey sample. The anti-HCV seroprevalence survey was performed in 6,283 volunteers (20- to 59-years-old) randomly selected from 45,377 consecutive individuals undergoing routine medical checkup in social security medical centers covering 4 of the 22 "regions" of France. Seventy-two volunteers were anti-HCV positive, a crude prevalence of 1.15%. Fifty percent of these positive volunteers also had an abnormal ALT level and 81% were HCV-RNA positive by polymerase chain reaction (PCR). The prevalence weighted for age, sex, and place of residence was 1.05% (95% CI: 0.75-1.34). The weighted prevalence was lower among men > 40-years-old (0.5%; 95% CI: 0.1-1.0) and was close to 1% in all other age and sex groups. Prevalence was inversely correlated with socioprofessional status with the highest rate bein...Continue Reading

Citations

Aug 25, 2005·Annals of Epidemiology·Elisabeth Delarocque-AstagneauUNKNOWN Hepatitis C Surveillance System Steering Committee
Jan 24, 2004·Journal of Hepatology·Sylvie Deuffic-BurbanThierry Poynard
Jun 21, 2005·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·J PillonelS Laperche
Jan 15, 1999·La Revue de médecine interne·S Pol, H Zylberberg
Jun 14, 2002·The Lancet Infectious Diseases·Sandro Vento, Francesca Cainelli
Apr 21, 2004·International Journal of Technology Assessment in Health Care·Sandrine LoubièreJean-Paul Moatti
Mar 23, 2011·Epidemiology and Infection·D LucidarmeB Filoche
Apr 12, 2000·Journal of Viral Hepatitis·R C CoppolaM Rizzetto
Mar 6, 2002·Journal of Viral Hepatitis·M I Memon, M A Memon
Oct 19, 2002·Transfusion·Josiane PillonelUNKNOWN Transfusion-Transmissible Agents Working Group of the French Society of Blood Transfusion
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J GournayJ P Galmiche
Apr 28, 2004·Infectious Diseases in Obstetrics and Gynecology·Youyin ChoyPeter G McGovern
Aug 12, 2009·European Journal of Public Health·Lisa A KingJean-Claude Desenclos
Dec 26, 2013·Quality Management in Health Care·William N SouthernAlain H Litwin
Oct 30, 1998·Journal of Gastroenterology and Hepatology·S KabaG C Farrell
Nov 25, 2011·Journal of Virology·Jayna RaghwaniOliver G Pybus
Mar 4, 2008·BMC Infectious Diseases·Charles E RamarokotoLeon P Rabarijaona
Oct 24, 2012·Virology Journal·Diana di FilippoMaria-Cristina Navas
Jan 13, 2000·Journal of Addictive Diseases·H D AbrahamL Marino
Jun 30, 2010·PloS One·Camila Malta RomanoUNKNOWN VGDN Consortium
Feb 12, 2005·Emerging Infectious Diseases·Mingdong ZhangThomas R O'Brien
Feb 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rania A Tohme, Scott D Holmberg
Jun 9, 2001·European Journal of Gastroenterology & Hepatology·S RiestraL Rodrigo
Sep 17, 2008·European Journal of Gastroenterology & Hepatology·Jean-François CadranelDominique Capron
Feb 1, 2010·Clinical Journal of Gastroenterology·Naoyuki NishimuraKentaro Sugano
Apr 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S DeufficA J Valleron
Dec 18, 2001·Journal of Medical Virology·A DomínguezL Salleras
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V DriesH P Dienes
Feb 13, 2003·Journal of Vascular and Interventional Radiology : JVIR·Nadège Baffoy-FayardUNKNOWN Study Group on Hygeine Practices in Interventional Radiology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.